Laboratory-Based Assessment of Metabolic Homeostasis and Mineral Balance in Adults from Zawia, Libya
A Retrospective Cross-Sectional Study
الكلمات المفتاحية:
Metabolic Syndrome، Real-World Evidence، Multi-biomarker Profiling، Zawia Medical Centre، El-sharara A-NC115 Libyan oilfieldالملخص
Integrated multi-biomarker profiling provides critical insights into subclinical metabolic disturbances. A retrospective, cross-sectional archive analysis was conducted utilizing laboratory records from Zawia Medical Centre (N=208). Ten biomarkers across five physiological axes were quantified. To address real-world missing data, pairwise deletion was applied. Inter-system cross-talk was calculated via Pearson correlation coefficients (r) using IBM SPSS (v26.0). The cohort exhibited glycaemic stress with an elevated mean Fasting Blood Sugar of 119.95 pm 46.38 {mg/dL} (n=133, Range: 29–370 mg/dL). Renal filtration markers showed marked dispersion: serum urea averaged 25.78 pm 11.25 {mg/dL} (n=109) and serum creatinine stood at 0.83 pm 0.85 {mg/dL} (n=92), skewed by advanced nephropathy outliers (Max: 8.50 mg/dL). Bivariate analysis exposed highly synchronized intra-hepatic activity between ALT and AST (r=0.834, P=0.003, n=10). Crucially, a distinct inter-system feedback loop linked macromineral stability with enzymatic pathways, where serum calcium (9.26 pm 1.33 {mg/dL}, n=61) correlated positively with Alkaline Phosphatase levels (r=0.460, P=0.041, n=20). Additionally, a significant musculoskeletal-renal filtration interface connected categorical Creatinine Status with circulating Creatine Kinase (r=0.958, P=0.042, n=4). Gender (66.3% female, 33.7% male) demonstrated complete biochemical uniformity across all axes (P>0.05). Correlated variations across glycaemic, renal, hepatic, and mineral biomarkers suggest the presence of interconnected metabolic disturbances rather than isolated physiological alterations. These findings provide valuable real-world evidence from western Libya and highlight the importance of strengthening standardized electronic laboratory databases to support regional screening strategies, disease surveillance, and chronic disease prevention efforts.
المراجع
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., ... & Smith, S. C. (2022). Metabolic syndrome—a new world-wide definition. The Lancet Diabetes & Endocrinology, 10(3), 155–158.
Alkazemi, D., Alsouri, N., Zafar, T., & Kubow, S. (2022). Hypomagnesemia and the metabolic syndrome among apparently healthy adults: A cross-sectional study. Nutrients, 14(24), 5257. https://doi.org/10.3390/nu14245257
Alsheikh, R., Aldulaimi, H., Hinawi, R., & Al-Thani, A. (2025). Association of serum magnesium and calcium with metabolic syndrome: A cross-sectional study from the Qatar Biobank. Nutrition & Metabolism, 22(1), 8. https://doi.org/10.1186/s12986-024-00892-y
American Diabetes Association. (2024). Standards of care in diabetes—2024. Diabetes Care, 47(Suppl. 1), S1–S295.
De Baaij, J. H. F., Hoenderop, J. G. J., & Bindels, R. J. M. (2022). Magnesium in man: Implications for health and disease. Physiological Reviews, 102(1), 1–46.
Dibaba, D. T., Chen, C., Lu, L., & Xin, P. (2021). Magnesium intake is inversely associated with the risk of metabolic syndrome in the REGARDS cohort study. Clinical Nutrition, 40(4), 2337–2342. https://doi.org/10.1016/j.clnu.2020.10.024
Elbadri, S., Alzunni, F., & Alkabeer, A. (2025). Vitamin D and metabolic health: Lipid and glucose profiles in Benghazi population. Libyan Medical Journal, 17(1), 5–15. https://doi.org/10.69667/lmj.2517102
El-Badri, S., et al. (2025). Metabolic risk profile in Libyan population studies. Libyan Journal of Medicine, 20(1), 123–132.
Elzain, E., Dakhil, A., Elyounsi, N., & Al-Haddad, S. (2025). Serum magnesium and sex-based differences in Libyan population: Health and quality of life implications. Azzaytuna University Journal, 56, 1–10. https://doi.org/10.35778/jazu.i56.a678
Emamat, H., Ghalandari, H., Totmaj, A. S., & Hekmatdoost, A. (2021). Calcium-to-magnesium ratio and non-alcoholic fatty liver disease development: A case-control study. BMC Endocrine Disorders, 21, 51. https://doi.org/10.1186/s12902-021-00721-w
European Society of Cardiology (ESC). (2021). ESC Guidelines on cardiovascular risk prevention. European Heart Journal, 42(34), 3227–3337.
Kashbour, R., et al. (2025). Metabolic syndrome and biochemical abnormalities in North African populations: Clinical insights. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 17, 189.
Moradmand, Z., Rouhani, P., & Saneei, P. (2025). Association between circulating levels of magnesium and metabolic syndrome: A systematic review and meta-analysis. Nutrition Reviews, 83(9), 1631–1640. https://doi.org/10.1093/nutrit/nuaf020
National Institutes of Health (NIH). (2023). Magnesium and calcium in human metabolism. U.S. Department of Health and Human Services.
National Kidney Foundation. (2022). Clinical practice guidelines for chronic kidney disease. American Journal of Kidney Diseases, 80(4), 1–112.
Nelson, D. L., & Cox, M. M. (2021). Lininger principles of biochemistry (8th Ed.). W. H. Freeman and Company.
World Health Organization (WHO). (2023). No communicable diseases country profiles: Libya. World Health Organization.
التنزيلات
منشور
كيفية الاقتباس
إصدار
القسم
الرخصة
الحقوق الفكرية (c) 2026 Shokri ayad halila

هذا العمل مرخص بموجب Creative Commons Attribution 4.0 International License.
